Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	80.45	89.55	49.63
Graham Fair Price	59.09	340.60	214.10
PEG	-92.47	-0.03	0.42
Price/Book	-48.16	0.75	1.45
Price/Cash Flow	-34.60	-4.36	6.67
Prices/Earnings	-78.90	10.96	-51.92
Price/Sales	-38.93	2.78	4.55
Price/FCF	-34.60	-4.36	6.67
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-16.54	0.18	0.21
Operating Margin	-76.82	0.02	0.09
ROA	158.58	0.01	< 0.005
ROE	< 0.005	0.02	145.66
ROIC	< 0.005	< 0.005	-48.84
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.28	-99.46
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	2.67	-0.80	-70.08
EPS QOQ	-1.25	3.49	180.24
FCF QOQ	1.83	-1.80	-1.48
Revenue QOQ	0.32	-0.14	-56.13
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	18.67	6.62	-64.52
Days Sales Outstanding (DSO)	153.35	231.43	50.92
Inventory Turnover	4.82	13.59	181.86
Debt/Capitalization	0.25	0.25	-0.93
Quick Ratio	1.63	1.71	4.64
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	540.35	548.46	1.50
Cash	274.57	150.40	-45.23
Capex	-17.53	-26.85	-53.16
Free Cash Flow	117.32	-94.39	-19.54
Revenue	172.23	148.39	-13.84
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.73	1.74	0.03
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.26	17.70	236.77
Naive Interpretation	Member

06 - Financial Health · Weak

Rating